DV
Dividend Vision

CPRX — Catalyst Pharmaceuticals, Inc.

No longer trading. This fund has been liquidated; the figures below are frozen at its final trading day.

Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals was acquired by Angelini Pharma for $31.50 per share in cash, and was removed from the Nasdaq in July 2026 when the deal closed. Shares traded at the deal price through their final session on July 17, 2026; holders received cash rather than stock in a successor, so there is no continuing listing to follow.

CPRX key facts

Asset type
Stock
Asset class
Equity
Inception date
11/08/2006
Distribution frequency
None
Last close
$31.49
Market cap
$3,854,925,568
Average volume
2544865.0
Beta
0.742
Payout ratio
0.0
P/E ratio
18.2023
Forward P/E
9.0488
EPS
$1.73